What sector does Aardvark Therapeutics, Inc. Common Stock (AARD) operate in?
Aardvark Therapeutics, Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Aardvark Therapeutics, Inc. Common Stock (AARD) current stock price?
As of the latest data, Aardvark Therapeutics, Inc. Common Stock stock price is $5.64, with a previous close of $4.90. Aardvark Therapeutics, Inc. Common Stock gained $0.74 in the last trading session, representing a 15.1% increase.
What is Aardvark Therapeutics, Inc. Common Stock (AARD) current market capitalization?
Aardvark Therapeutics, Inc. Common Stock market cap is approximately 122.80 million.
What is Aardvark Therapeutics, Inc. Common Stock (AARD) Earnings Per Share (EPS)?
The trailing EPS is -$2.53, and the forward EPS is -$3.59.
What is Aardvark Therapeutics, Inc. Common Stock (AARD) EBITDA?
Aardvark Therapeutics, Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -16.31 million.
Does Aardvark Therapeutics, Inc. Common Stock (AARD) pay dividends?
No. Aardvark Therapeutics, Inc. Common Stock does not pay a dividend.
When is Aardvark Therapeutics, Inc. Common Stock (AARD) next earnings report?
Aardvark Therapeutics, Inc. Common Stock is expected to release its next earnings report on March 31, 2026.
What is Aardvark Therapeutics, Inc. Common Stock (AARD) beta (volatility) score?
Aardvark Therapeutics, Inc. Common Stock has a beta of 0.313, indicating lower volatility than the overall market.